Voltage Metals Is In Search Of The Vital Input Products Powering A Multi-Billion Dollar Industry
During the last decade, Tesla, Inc. (Nasdaq: TSLA) has been the clear leader in the rapidly growing electric vehicle (EV) industry and has reported a massive increase in the number…
C-Bond Systems Is Flying Under The Radar
As we approach the end of the year, our team has become highly focused on identifying businesses that are flying under the radar and are well positioned to capitalize on…
Lexaria Biotechnology Is Nearing An Inflection Point!
A few weeks ago, we highlighted Lexaria Biotechnology (Nasdaq: LEXX) as a biotech firm that is flying under the radar. The company is led by a management team that is…
Safe Supply Streaming: A Deep Dive
Although there is a certain level of immediate attraction to investment opportunities in emerging industries such as the cannabis or psychedelic sectors, we believe that investors must be selective when…
Lexaria to Evaluate Impact of DehydraTECH on Oral Performance of GLP-1 drugs used in products such as Ozempic, Wegovy and Rybelsus, Alone or Together with DehydraTECH-CBD
KELOWNA, BC / ACCESSWIRE / September 21, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces its intention to launch new…
Lexaria Provides Update on Investigational New Drug Application Progress
KELOWNA, BC / ACCESSWIRE / August 30, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is providing this update on the status…
CEO Spotlight: FendX Technologies
This is a paid advertisement on behalf of FendX Technologies Inc. Today, we have FendX Technologies CEO Carolyn Myers with us and we are excited to learn more about her…
Lexaria’s DehydraTECH-Nicotine Faster than ZYN and on!
KELOWNA, BC / ACCESSWIRE / August 9, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to report results from…
FendX Technologies: A Deep Dive
This is a paid message on behalf of FendX Technologies Inc. Although the COVID pandemic created numerous challenges for the global economy, it facilitated the advancement of several industries. From…
Lexaria’s Plans to Study Weight Loss and Diabetes Control in a Human Clinical Study with DehydraTECH-CBD
KELOWNA, BC / ACCESSWIRE / August 2, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to report its intention to…
Lexaria Incorporates New Subsidiary for CPG Products and Updates Human Nicotine Study
KELOWNA, BC / ACCESSWIRE / July 28, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces it has incorporated a new wholly-owned…
